Stage IVA Laryngeal Verrucous Carcinoma
specificStage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); T4a: Supraglottis: Moderately advanced local disease. Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus). Glottis: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues
10
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Stage IVA Laryngeal Verrucous Carcinoma(10)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive | 55.0 |
| 2 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 55.0 |
| 3 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 55.0 |
| 4 | NCI Comprehensive | 55.0 |
| 5 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive | 55.0 |
| 6 | University of Illinois Cancer CenterChicago, IL | 55.0 |
| 7 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 55.0 |
| 8 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL | 55.0 |
| 9 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ | 55.0 |
| 10 | Princess Margaret Cancer CentreToronto, ON | 55.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →